top of page

1-minute AI Eye Exam. Anytime. Anywhere.

Deploy FDA-cleared autonomous AI to close the diabetic eye care gap and eliminate preventable blindness at the point of care

FDA-cleared, autonomous AI DR screening built for primary care.

Deploy with handheld or desktop cameras, operated by any staff member.

icons-1.png

1 minute autonomous AI diagnosis,

1 image per eye

Untitled design (4).png

Seamless EHR Integration for automated reporting, billing and referral

icons-5.png

No physician interpretation needed

icons-4.png

CPT 92229 reimbursable, closes HEDIS gaps

AEYE-DS

Book a demo

Book a Demo To Learn More

Early Detection Prevents Blindness

Accessible and affordable screening for diabetic retinopathy is vital to help ensure patients with diabetes receive sight-saving treatment.

More than

830M

people in the world live with diabetes

Over

40M

people with in US

live with diabetes

At least

85%

of people over 40 with diabetes will develope diabetic retinopathy

< 50%
Less than

of patients with diabetes in the US adhere to their annual eye exams

AEYE-DS - The only FDA-cleared solution providing instant AI diagnosis using handheld or tabletop cameras

bottom of page